Author

Lusi Feng

Institutions: Sichuan University, West China Hospital of Sichuan University, State Key Laboratory of Biotherapy

Observed institutions: Sichuan University, West China Medical Center of Sichuan University, West China Hospital of Sichuan University, State Key Laboratory of Biotherapy

OpenAlex ID: A5066840430

Case Report: Favorable Response and Manageable Toxicity to the Combination of Camrelizumab, Oxaliplatin, and Oral S-1 in a Patient With Advanced Epstein–Barr Virus-Associated Gastric Cancer

2022 · Wanrui Lv, Ke Cheng, et al. · Frontiers in Oncology · 8

Integrated Single‐Cell and Spatial Transcriptome Reveal Metabolic Gene SLC16A3 as a Key Regulator of Immune Suppression in Hepatocellular Carcinoma

2024 · Qianlong Kang, Xiaomeng Yin, et al. · Journal of Cellular and Molecular Medicine · 7

Tumor-intrinsic PHGDH inhibition sensitizes colorectal cancer to PD-1 blockade via α-ketoglutarate–mediated macrophage reprogramming

2026 · Jieping Qiu, Jingwen Wei, et al. · Drug Resistance Updates

Dual blockade of PD-1 and NKG2A prevents NK cell senescence and reprograms the immunosuppressive microenvironment in pancreatic cancer

2026 · Yu Zhang, Xueyan Zhou, et al. · Cell Reports

Case Report: Contrast-enhanced ultrasonography for evaluating a newly detected contralateral pulmonary lesion during non-small cell lung cancer chemoimmunotherapy

2026 · Yang Liu, Lusi Feng, et al. · Frontiers in Immunology

Works count: 5

Citation count: 15

H-index: 2

I10-index: